Clinical efficacy of recombinant gonadotrophins

This publication has 52 references indexed in Scilit:

• Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates
  Fertility and Sterility, 1998
• FSH bioactivity in commercial preparations of gonadotropins
  Theriogenology, 1998
• The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in-vitro fertilization.
  Human Reproduction, 1998
• Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial
  Fertility and Sterility, 1998
• Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques
  Human Reproduction, 1997
• Immunology: Pregnancy and birth in an in-vitro fertilization cycle after controlled ovarian stimulation in a woman with a history of allergic reaction to human menopausal gonadotrophin
  Human Reproduction, 1996
• Ovulation induction: The effects of ovulation induction with gonadotrophins on the ovary and uterus and implications for assisted reproduction
  Human Reproduction, 1995
• Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients
  Human Reproduction, 1994
• Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage
  BJOG: An International Journal of Obstetrics and Gynaecology, 1993
• FACTORS INVOLVED IN THE INDUCTION OF FERTILE OVULATION WITH HUMAN GONADOTROPHINS
  BJOG: An International Journal of Obstetrics and Gynaecology, 1969